Lower lumbar disc disorders pose a significant problem in an aging society with substantial socioeconomic consequences. Both inner tissue (nucleus pulposus) and outer tissue (annulus fibrosus) of the intervertebral disc are affected by such debilitating disorders and can lead to disc herniation and lower back pain. In this study, we developed an alginate-collagen composite porous scaffold with shape-memory properties to fill defects occurring in annulus fibrosus tissue of degenerated intervertebral discs, which has the potential to be administered using minimal invasive surgery. In the first part of this work, we assessed how collagen incorporation on preformed alginate scaffolds influences the physical properties of the final composite scaffold. We also evaluated the ability of annulus fibrosus cells to attach, migrate, and proliferate on the composite alginate-collagen scaffolds compared to control scaffolds (alginate only). In vitro experiments, performed in intervertebral disc-like microenvironmental conditions (low glucose and low oxygen concentrations), revealed that for alginate only scaffolds, annulus fibrosus cells agglomerated in clusters with limited infiltration and migration capacity. In comparison, for alginate-collagen scaffolds, annulus fibrosus cells readily attached and colonized constructs, while preserving their typical fibroblastic-like cell morphology with spreading behavior and intense cytoskeleton expression. In a second part of this study, we investigated the effects of alginate-collagen scaffold when seeded with bone marrow derived mesenchymal stem cells. In vitro, we observed that alginate-collagen porous scaffolds supported cell proliferation and extracellular matrix deposition (collagen type I), with secretion amplified by the local release of transforming growth factor-b3. In addition, when cultured in ex vivo organ defect model, alginate-collagen scaffolds maintained viability of transplanted mesenchymal stem cells for up to 5 weeks. Taken together, these findings illustrate the advantages of incorporating collagen as a means to enhance cell migration and proliferation in porous scaffolds which could be used to augment tissue repair strategies.
Introduction
Intervertebral disc (IVD) degeneration is known to be the predominant contributor to chronic low back pain (LBP). It is a major concern in an aging society and has been reported to affect up to five million patients in the USA in 2011 1 with estimated costs of $100 billion due to healthcare costs and lost productivity. 2 An estimated 85% of the adult population experiences LBP at least once during their lives. 3 Early stage treatments such as physical therapy and pain management with analgesics and anti-inflammatory drugs may provide pain relief, but offer no significant amelioration for acute stage degeneration. 4 For severe cases, disc herniation may be alleviated through surgical dissection of the bulging tissue (via discectomy), and complete disc removal followed by spinal fusion can be performed for advanced degenerated conditions. 5 However, none of these available treatments aim to repair or regenerate the disc itself and not surprisingly surgical revisions are frequent. In this context, research into biomaterial and cell-based approaches has intensified over the last decade to treat both nucleus pulposus (NP) and annulus fibrosus (AF) tissues. [6] [7] [8] [9] Recent attempts to close AF defects and promote tissue repair in an ovine model using a partially degradable preformed composite implant made of polyglycolic acid and polyvinylidene have been reported. 10 These implants were capable of successfully retaining the NP within the central region of the IVD impeding disc herniation and also supported cell infiltration and matrix deposition after 12 weeks. However, evidence of AF tissue damage adjacent to the implantation site was observed and, as highlighted by the authors, such surgical procedures (biomaterial implantation plus suture placement) were extremely demanding for the surgeon. Limitations of employing preformed scaffolds include difficulties with drug incorporation and/or cell seeding issues as well as their inability to fill irregularly sized defects. 11 For this reason, extensive research involving injectable-biomaterial candidates for NP regeneration has been explored, but surprisingly a limited number of similar systems have been targeted for AF tissue to date. [12] [13] [14] [15] [16] High-density injectable collagen gels have been investigated to fill punctured AF tissue in a rat tail model. Although no further sign of disc degeneration was observed in terms of hydration, as evaluated using MRI and disc height measurements post-implantation, incomplete AF tissue regeneration was observed in the inner region of the newly formed tissue, combined with a fibrous capsule in the outer part with dissimilarity in terms of extracellular matrix (ECM) composition compared to native AF tissue. 13 In an attempt to fill AF defects and to promote tissue repair, we have previously reported the development of injectable porous scaffolds fabricated through the freeze drying of covalently crosslinked alginate based on carbodiimide chemistry. 16 Such scaffolds exhibit high pore interconnectivity and shape-memory properties ideal for this specific application, as it can expand and fill defects once hydrated. Although the shape-memory behavior of covalently crosslinked alginate is highly attractive, a disadvantage of this material is the lack of binding sites available for direct cell attachment. In an effort to increase the biocompatibility of these scaffolds, we incorporated collagen onto covalently crosslinked porous alginate scaffolds. Advantages of using collagen as a biomaterial for tissue engineering are well documented. 17, 18 Collagen is highly biocompatible and is the most abundant organic material in the body. 19 Collagen has been successfully employed in hydrogel form or as cell culture substrates with several collagen-based matrices for tissue regeneration in commercial use. 20 However, collagen-based constructs are inherently mechanically weak and are susceptible to shrinkage as they cannot withstand the forces exerted due to cell contraction. 21, 22 To alleviate such limitations, we chose to combine collagen as a biological coating agent on covalently crosslinked alginate structure, which provides mechanical reinforcement.
The global objective of this study was to evaluate how incorporation of collagen in preformed alginate scaffold influences the physical properties of the shape-memory scaffolds and to assess its effect on AF cell migration and scaffold colonization in vitro and in an ex vivo organ culture model. Finally, we explored the benefits of alginate-collagen (Alg-Coll) scaffolds when seeded with bone marrow derived mesenchymal stem cells (MSCs) both in vitro and ex vivo to assess (i) the survival of the MSCs postimplantation, and (ii) if the presence of MSCs could promote resident AF cell recruitment into the implanted porous scaffold.
Materials and methods

Fabrication of injectable shape-memory scaffolds
Fabrication of alginate (Alg) scaffold. Porous alginate scaffolds were fabricated through a covalent crosslinking method using carbodiimide chemistry as previously described. 16 Sodium alginate (alginate Pronova UP LVG) was purchased from FMC Biopolymer (Novamatrix, Sandvika, Norway) and all other chemicals were obtained from Sigma-Aldrich (Arklow, Ireland). Briefly, alginate (final concentration 2%, w/v) was dissolved in morpholine ethanesulfonic (MES) acid buffer pH 6.0 and sterile solutions of Nhydroxysuccinimide (NHS) and 1-ethyl-3-(dimethylaminopropyl) carbodiimide (EDC) were added to the alginate solution at a final molar ratio of 2:1:2 for EDC:NHS:COO -. Finally, the bifunctional crosslinker (adipic acid dihydrazide) was added to the reactive solution at a concentration of 45% (depending on n NH2 /n COOH ), rapidly homogenized and cast in a mold. The crosslinking reaction was allowed to proceed overnight followed by repeated washing in deionized (DI) water to remove any unreacted reagents. Porous scaffolds were obtained using a freeze-drying process (Labconco Triad TM , Kansas City, MO USA), at a freezing temperature (T ¼ À30 C) to allow ice crystallization and finally sublimated under vacuum (0.2 mbar) for 18 h at a temperature of À10 C to create the porous network. After the freeze-drying process, scaffolds were created using a sterile biopsy punch (3 or 5 mm Ø Â 3 mm H).
Fabrication of Alg-Coll scaffolds. Collagen type I (extracted from rat tail, BD Biosciences, Oxford, United Kingdom) was incorporated into the preformed freeze-dried porous alginate scaffold during a rehydration step. Briefly, alginate scaffolds (Alg) were individually collapsed using tweezers and rehydrated with sterile collagen solutions of different concentrations (0, 1.13, 2.26, and 4.52 mg/ml corresponding to the groups A, B, C, and D, respectively). The Alg-Coll scaffolds were subsequently freeze-dried using the same protocol previously described 16 and subjected to dehydrothermal treatment (at 110 C for 24 h) in order to physically crosslink the collagen chains and stabilize the structure. This protocol was selected as it has been previously demonstrated to limit the denaturation of collagen chains in composite scaffolds. 23, 24 Scaffold characterization Determination of swelling ratio. In order to evaluate the influence of collagen incorporation on water uptake capacity and on shape-memory recovery behavior of the alginate-based scaffolds, the swelling ratio of groups A, B, C, and D was determined as follows. Scaffolds (5 mm Ø Â 3 mm H, n ¼ 3) were collapsed with tweezers for 30 s, weighed (W 0 ), and subsequently rehydrated with DI water for 5 min, which was a sufficient period of time to allow scaffolds to fully swell. Excess water was removed, the wet weight recorded (W f ), and the final swelling ratio (SWr, expressed as a percentage) was calculated according to the formula
Collagen incorporation. The final collagen content of the different groups (A, B, C, D) of Alg-Coll scaffolds was determined from measuring the hydroxyproline content of digested samples (see ''Quantitative biochemical analysis'' section) (n ¼ 3). Constructs were evaluated by scanning electron microscope (SEM, see ''SEM examination'' section) and through histological staining (Picro Sirius Red for collagen staining, see ''Histology and immunohistochemistry'' section) to ascertain the homogeneity of collagen distribution and to evaluate the micro-structure and porosity.
Assessment of biomechanical properties. Constructs from groups A and C (5 mm Ø Â 3 mm H, n ¼ 3) were mechanically tested under confined compression conditions in phosphate buffed saline (PBS) at room temperature using a standard materials testing machine with a 5 N load cell (Zwick Z005, Roell, Germany). A preload of 0.01 N was applied to ensure that the top surface of the construct was in direct contact with the porous indenter. Stress relaxation tests were performed, consisting of a ramp and hold cycle with a ramp displacement of 1 mm/s until 10% strain was obtained (the maximal stress recorded corresponding to the peak stress) and maintained until equilibrium was reached for at least 45 min (corresponding to the equilibrium stress). The aggregate compressive equilibrium modulus was calculated by taking the stress determined at complete relaxation (equilibrium) and dividing by the applied strain (10%), respectively.
Incorporation of transforming growth factor-3 (TGF-3) and determination of release profile from alginate-based scaffolds. The influence of collagen incorporation on TGF-b3 release profile from alginate-based scaffolds (5 mm Ø Â 3 mm H, n ¼ 3) was evaluated using an enzyme linked immunosorbent assay (ELISA). Briefly, scaffolds (Group A, alginate only compared to Group C, Alg-Coll scaffolds) were collapsed with tweezers and rehydrated with 50 ml of a solution of human TGF-b3 (2.4 mg/ml, PeproTech, London, UK). TGF-b3 loaded scaffolds were incubated in 1 ml of PBS at 37 C, and at specific time points (1, 2, 3, 5, 7, 10, and 15 days) the total volume of PBS was removed and replaced with fresh PBS solution and assessed using an ELISA kit according to the manufacturer's instructions (R&D Systems, UK).
AF and bone marrow derived MSC isolation and culture expansion
Porcine AF and MSCs were harvested from the IVDs and from the bone marrow of the femora, respectively (& 40 kg/4 months old) within 3 h of sacrifice, as previously described. 16, 25 Under aseptic conditions, AF tissue was harvested, finely diced, and enzymatically digested in 2.5 mg/ml pronase solution (Calbiochem, Merck Millipore, Darmstadt, Germany) for 1 h followed by collagenase digestion at 1 mg/ml (Invitrogen, Dublin, Ireland) at 37 C under constant rotation in serum free low-glucose Dulbecco's modified eagles medium (1 mg/ml D-Glucose, 200 mM L-Glutamine; lg-DMEM) containing antibiotic/antimycotics (100 U/ml penicillin, 100 mg/ml streptomycin) (all GIBCO, Invitrogen) and amphotericin B (0.25 mg/ml, Sigma-Aldrich). Digested tissue/cell suspensions were passed through a 100 mm cell strainer to remove tissue debris and washed three times by repeated centrifugation at 650 g for 5 min. AF cells were plated at 5 Â 10 3 cells/cm 2 and expanded in T-175 flasks (Sarstedt, Ireland) in XPAN, corresponding to lg-DMEM supplemented with 10% foetal bovine serum (FBS), penicillin (100 U/ml)-streptomycin (100 mg/ml) amphotericin B (0.25 mg/ml), supplemented with 5 ng/ml fibroblast growth factor-2 (FGF-2; PeproTech, United Kingdom) at 37 C in a humidified atmosphere containing 5% CO 2 , with medium changed every 3-4 days.
Mononuclear cells were isolated from the bone marrow and plated at 10 Â 10 6 cells in T-75 cm 2 flasks to allow for colony formation. MSCs were maintained in the same XPAN media supplemented with FGF-2 than for the AF cells expansion. Cultures were washed in PBS after 72 h. When passaged, MSCs were plated at 5 Â 10 3 cells/cm 2 and expanded to passage 2 in a humidified atmosphere at 37 C and 5% CO 2 , with medium changed every 3-4 days.
In vitro AF cell migration study
Agarose molds were created (agarose type VII, Sigma-Aldrich) with a cavity of 70 ml in the center of each mold (Part A, Figure 4 ). Fifty microliters of AF cell suspension at a density of 8.5 Â 10 6 cell/ml, similar to the native density of AF tissue, 26 was pipetted into each mold. Alginate only scaffolds (Group A, Alg) and Alg-Coll scaffolds (Group C, Alg-Coll) (3 mm Ø Â 3 mm H, n ¼ 3) were collapsed and loaded with either a solution of TGF-b3 (concentration of 2.4 mg/ ml) or PBS (control). Subsequently, each scaffold was placed into the center of agarose wells and maintained in 24-well plates (Costar Corning, Fisher Scientific, Ireland) with 1 ml of XPAN (without FGF-2 supplementation). After 2 days, scaffolds were transferred to fresh 24-well plates with media changed every 3-4 days. Scaffolds were maintained at 37 C in a humidified incubator in low oxygen conditions (5% O 2 ). Constructs were assessed at days 2, 10, and 21 in terms of cell viability and cytoskeleton fluorescence staining (n ¼ 1/2), cell morphology using SEM (n ¼ 1/2), DNA content (n ¼ 3), and histology (n ¼ 2) (n ¼ 6 for each group and each time point).
Cytocompatibility of MSCs on alginate-based scaffolds
MSCs were seeded onto fully compressed alginate (Group A) and Alg-Coll scaffolds (Group C) (5 mm Ø Â 3 mm H). Briefly, MSCs (20 Â 10 6 cells/ml) were triturated in a solution of TGF-b3 (concentration of 2.4 mg/ml) or in PBS (control). Scaffolds were rehydrated with 50 ml of the MSCs/PBS solution or with MSCs/TGF-b3 solution. After seeding, scaffolds were maintained at 37 C in a humidified incubator for 2 h to allow for cell attachment and transferred to 24-well plates with 2 ml of XPAN with and without TGF-b3 (10 ng/ml) supplementation (n ¼ 6 per group). Media was changed twice weekly during the 21-day culture period of the experiment. After 21 days constructs were assessed in terms of cell viability (n ¼ 1), biochemical content (n ¼ 3), and histology (n ¼ 2).
Ex vivo organ culture model
Preparation of full IVDs from bovine coccygeal for ex vivo organ culture. IVDs were harvested aseptically from bovine tails as previously described. 27 Briefly, bovine tails (18 months old) were obtained from an abattoir within 3-5 h of sacrifice. As illustrated in Figure 1 , bovine tails were first cleaned with a solution of iodinated povidone (1:100) for 15 min (Videne Antiseptic Solution, Ecolab Ltd, Garforth, UK) and, under sterile conditions, tissues (muscles and tendons) were removed to expose the vertebral endplates of the IVDs (Step 1). Using a custom-made blade holder, intact IVDs including the cartilaginous endplates Step 1: Bovine tails were cleaned and tissues were trimmed to facilitate the localization of the IVDs.
Step 2: Using a custom-made blade holder, intact IVDs were cut, cleaned, and maintained hydrated.
Step 3: Defects in the AF tissue of each IVD were created using a biopsy punch (Ø 4 mm Â 4 mm deep). Using a catheter of $1 mm diameter, one scaffold was injected per defect and rehydrated to completely fill the volume of the defect.
Step 4: IVDs were finally cultivated for 5 weeks in an orbital shaker.
were cut, thoroughly cleaned using a jet lavage system (Stryker Õ Interpulse Irrigation System, Stryker, UK) (in order to enhance the nutrient diffusion through the endplates), and maintained hydrated in sterile gauze soaked with PBS containing penicillin (100 U/ml)-streptomycin (100 mg/ml) and amphotericin B (0.25 mg/ml) (Step 2). Defects in the AF tissue were created using a biopsy punch (Ø 4 mm, four defects per IVD) and, subsequently, one scaffold (Ø 5 mm Â 4 mm H) was collapsed and inserted into a custom-made catheter of $1 mm diameter, injected into the defect site and rehydrated to completely fill the volume of the defect (Step 3). IVDs (n ¼ 5) were cultured for 5 weeks in 100 ml of XPAN under gentle agitation (orbital platform shaker, PSU-10i, Biosan, Latvia) at 37 C in normoxic conditions (Step 4), with medium changed twice weekly. Viability of AF cells over the period of culture was evaluated (days 1, 21, and 35) on control IVD (n ¼ 1) using LIVE/DEAD Õ staining on biopsied AF tissues.
Cell migration study on alginate-based scaffold on ex vivo model. The first ex vivo experiment aimed to investigate the ability of alginate-based scaffolds to facilitate recruitment of AF cells through migration from the tissue surrounding the defects. Alg (Group A) and Alg-Coll (Group C) scaffolds (5 mm Ø Â 3 mm H, n ¼ 4 per group) were prepared as previously described, collapsed, and injected into the defect site (4 mm Ø Â$ 4 mm deep). A solution of growth factor (50 ml of TGF-b3 at 2.4 mg/ml) was injected into the defect, fully rehydrating the scaffold and allowing it to expand to fill the defect. The IVDs containing ''TGF-b3-loaded Alg'' and ''TGF-b3-loaded Alg-Coll'' scaffolds (n ¼ 1 IVD per group and four scaffolds per IVD) were maintained in XPAN for 5 weeks. At the end of the culture period, scaffolds were carefully removed and assessed in terms of cell viability (n ¼ 1), histology (n ¼ 2), and SEM (n ¼ 1).
The second ex vivo experiment evaluated the potential to deliver MSCs directly into the scaffold after its placement and to investigate (i) the survival of the MSCs postimplantation, and (ii) if the presence of MSCs promoted resident AF cell recruitment. In order to monitor the fate of the injected cells, MSCs were first labeled using red fluorescent cell membrane labeling PKH26 according to the manufacturer's instructions (Sigma-Aldrich). The protocol for this experiment is similar to the previously described study on acellular scaffolds, except that the rehydration of implanted scaffolds was achieved with a solution of 50 ml containing the growth factor TGF-b3 (2.4 mg/ml) combined with fluorescently labeled MSCs (20 Â 10 6 cells/ml). The IVDs containing ''MSC-laden TGF-b3-loaded Alg'' and ''MSC-laden TGF-b3-loaded Alg-Coll'' scaffolds (n ¼ 1 IVD per group and four scaffolds per IVD) were maintained in XPAN for 5 weeks. At the end of the organ culture experiment, scaffolds were carefully removed and assessed as previously described.
Fluorescent cell staining and labeling
Cell viability. Cell viability was assessed using a LIVE/ DEAD Õ viability/cytotoxicity assay kit (Invitrogen, Bio-science, Ireland). Briefly, constructs were cut in half, washed in PBS followed by incubation in PBS containing 2 mM calcein AM (green fluorescence for live cells) and 4 mM ethidium homodimer-1 (red fluorescence for dead cells; both from Cambridge Bioscience, UK). Sections of constructs were washed in PBS, imaged at magnifications Â10 and Â20 with an Olympus FV-1000 Point-Scanning Confocal Microscope (Southend-on-Sea, UK) and analyzed using FV10-ASW 2.0 Viewer software.
Due to the spectro-incompatibility between the fluorescence emitted from the ethidium and that of PKH26, for experiments using PKH26-labeled MSCs, ethidium was replaced by another DNA-binding probe, DRAQ7 TM (Biostatut Limited, Leicestershire, UK) to stain nonviable cells (dilution of 1:100). Due to the low number of samples per group (n ¼ 1) only qualitative results of the live and dead cells are presented.
Actin cytoskeleton staining. Scaffold cross-sections were incubated with fluorescent rhodamine-conjugated phalloidin (dilution 1:40, Biotium, Hayward, USA) combined with Hoechst (4 0 ,6-diamidino-2-phenylindole (DAPI), dilution 1:50, VWR, Ireland) in order to identify cell morphology and observe F-actin filaments of the cytoskeleton (in red) and the nucleus of the cell (in blue).
Quantitative biochemical analysis
To quantify the accumulation of biochemical constituents, constructs were digested with 125 mg/ml papain in 0.1 M sodium acetate, 5 mM L-cysteine-HCl, 0.05 M EDTA, pH 6.0 (all from Sigma-Aldrich) at 60 C under constant rotation for 18 h (n ¼ 3 for each group). DNA content of each sample was quantified using the Hoechst Bisbenzimide 33258 dye assay, with a calf thymus DNA standard. Total collagen content was estimated by measuring the hydroxyproline content using trans-4-Hydroxy-L-proline standard stock solution at 1 mg/ ml (Fluka, Ireland). Samples were hydrolyzed at 110 C for 18 h in 38% HCl and assayed using a chloramine-T assay. 28 
SEM examination
Prior to SEM observation, scaffolds were cut in half and fixed with 4% paraformaldehyde (PFA) solution in sodium cacodylate-barium chloride buffer at 4 C overnight followed by repeated washings in PBS. Fixed samples were dehydrated through successive graded ethanol baths (10-100%) followed by critical point drying with CO 2 . Scaffolds were then sputter coated with an approximate 10 nm thick gold film and examined by SEM (Tescan Mira FEG-SEM XMU, Libusˇina, Czech Republic) using a lens detector with a 5 kV acceleration voltage at calibrated magnifications.
Histology and immunohistochemistry
Staining of matrix deposition in the scaffolds was performed after fixation, dehydration, and wax embedding. Briefly, constructs were removed from the culture media, washed in PBS, and fixed in 4% PFA solution in sodium cacodylate-barium chloride buffer overnight at 4 C. After removing the fixative and washing, samples were gradually dehydrated through 70-100% ethanol series with a final xylene change, before embedding in wax. Sections of 8 mm were obtained with a microtome (Leica RM2125RT, Ashbourne, Ireland) and affixed to microscope slides (Polylysine TM , VWR, Dublin, Ireland). Prior to staining, sections were dewaxed and rehydrated in 100 to 70% ethanol baths followed by distilled water. Cellular colonization and matrix deposition was stained using hematoxylin and eosin (H&E), whereas collagen distribution was assessed histologically using Picro-Sirius Red. Cellular infiltration on rehydrated scaffold sections was observed using nuclear fluorescent DAPI staining.
Collagen types I and II were evaluated through immunohistochemistry. Briefly, sections were treated with peroxidase, followed by treatment with chondroitinase ABC (Sigma-Aldrich) in a humidified environment at 37 C to enhance permeability of the ECM. Sections were incubated with goat serum to block nonspecific sites and collagen type I (ab6308, 1:400; 1 mg/ml), collagen type II (ab3092, 1:100; 1 mg/ml) primary antibodies (mouse monoclonal, Abcam, Cambridge, UK) were applied for 18 h at 4 C. Next, the secondary antibody (Anti-Mouse IgG biotin conjugate, 1:200; 2.1 mg/ml) (Sigma-Aldrich) was added for 1 h followed by incubation with ABC reagent (Vectastain PK-400, Vector Labs, Peterborough, UK) for 45 min. Color was developed using the Vectastain ABC reagent followed by exposure to peroxidase DAB substrate kit. Negative and positive controls of porcine ligament and cartilage were included for each batch.
Statistical analysis
Statistical analyses were performed using GraphPad Prism (version 5) software with three samples analyzed for each experimental group. One way ANOVA was used for analysis of variance with Bonferroni's posttests to compare between groups. Results are reported as mean AE standard deviation. Significance was accepted at a level of p < 0.05.
Results
Physical characterization of alginate and Alg-Coll scaffolds
Alg-Coll scaffolds were successfully fabricated with specific amounts of collagen as determined through biochemical analyses (Figure 2(a) ). The intrinsic shapememory property of covalently crosslinked alginate was not affected with the incorporation of collagen, with all scaffolds (Groups A-D) exhibiting similar swelling ratios (Figure 2(b) ). The average weight of the scaffolds (5 mm Ø Â 3 mm H) before rehydration was 1.12 AE 0.12 mg and after rehydration and swelling was 35.93 AE 4.36 mg (data not shown), which globally corresponds to swelling ratios ranging between 3000 and 4000%, independent of the collagen incorporation. Up to 7% of collagen could be successfully incorporated into the scaffold (expressed as a percentage compared to alginate dry weight) using a concentration of collagen solution at 2.26 mg/ml. In this study, we observed that the incorporation of collagen into the alginate porous scaffold did not significantly alter the mechanical properties of the composite scaffold compared to alginate only, in terms of peak stress and aggregate compressive equilibrium modulus (Figure 2(c) ). Higher concentrations (i.e. 4.52 mg/ml) did not enhance the final amount of collagen into the scaffold due to the increased solution viscosity and difficulties with infiltration. Alginate scaffolds containing 7% collagen retained their initial geometry after rehydration with PBS within 5 s (Figure 2(d) , Supplementary Video S.1 and SD1 (A-C)). Interestingly, this scaffold exhibits excellent elastic properties, as it is able to rapidly recover its original shape after compression (SD1 D-F). Collagen coating deposition onto the alginate struts was confirmed by microscopic analyses (i.e. using SEM) (Figure 3 (a) to (d)). We observed that with low concentrations of collagen (i.e. 1.13 and 2.26 mg/ml), collagen fibers were homogenously distributed into the alginate porous structure (Figure 3(b) and (c)). In contrast, for higher collagen concentration, deposition of collagen was confined to the outer part of the scaffold (Figure 3(d) Sirius Red) did not permit discrimination due to background staining of the alginate itself (Figure 3 (e) to (h)). However, from SEM observations, we noted that for a collagen concentration of 4.52 mg/ml, a dense layer of collagen was formed around the periphery of the scaffold. Consequently, for all subsequent in vitro culture experiments we selected Group C Alg-Coll scaffold (2.26 mg/ml), with the Alg scaffold (Group A) serving as a control.
AF cell migration in alginate-based scaffolds
In vitro assessment. The addition of collagen into alginate scaffolds had a considerable effect on AF cell migration ( Figure 4 ). By day 2, DNA quantification of Alg (Group A) and Alg-Coll scaffolds (Group C) revealed that the incorporation of collagen into the alginate scaffold significantly enhanced cellular attachment to the scaffold (Figure 4(a) ). Few cells were observed to adhere to alginate only scaffolds (Alg) compared to Alg-Coll scaffolds in which a higher proportion of cells were present in the peripheral regions of these scaffolds (Figure 4(b) and (d)). Interestingly, at days 10 and 21, cells did not proliferate as the total amount of DNA for each group was similar (p > 0.05) (Figure 4(a) ). Histological analyses revealed that for control scaffolds (Alg), cells did not colonize the scaffold but remained in small clusters during the 3 weeks of the in vitro experiment ( Figure  4(c) ). In contrast for Alg-Coll scaffolds, cells migrated and colonized the entire volume (Figure 4(e) ). Minor differences between TGF-b3 loaded and nonloaded scaffolds was observed for both Alg only and Alg-Coll groups. In order to investigate this moderate bioactivity of the TGF-b3 loaded scaffold, we examined the release kinetics of TGF-b3 growth factor using an ELISA. The release kinetics of TGF-b3 from both Alg and composite Alg-Coll scaffolds was rapid with almost 98% released within the initial 24 h (SD 2), which could possibly explain the limited bioactivity on AF cells.
Freeze-dried scaffold
Part A: Materials and Methods Part B: Results
Additional in vitro experiments revealed that both scaffold types were capable of supporting cell viability ( Figure 5 ). However, there were distinct differences in cell shape depending on scaffold type. Specifically, by day 21 for Alg scaffolds, AF cells remained viable ( Figure 5(a) ) but H&E staining showed that cells did not migrate and colonize the scaffold structure ( Figure  5(b) ). Instead small clusters of cells were observed ( Figure 5(c) and (d) ). Furthermore, the limited presence of F-actin in the cytoskeleton demonstrates that the cells were not able to readily attach to the alginate scaffold material ( Figure 5(e) ). In comparison, for Alg-Coll scaffolds, after 21 days, AF cells exhibited excellent viability ( Figure 5(f) ) and have migrated and penetrated into the volume of the scaffold (Figure 5(g) and (h)) with no cell clustering observed. Indeed, AF cells exhibited a pronounced spindle-shape morphology ( Figure  5 (i)) and cytoskeleton stained intensively positive for F-actin protein ( Figure 5(j) ).
Ex vivo organ culture assessment. Scaffolds implanted into the defects remained in situ and intact for the entire duration of 5 weeks (Figure 6(a) ). LIVE/DEAD TM assay on control IVD tissue showed that the viability of AF cells was maintained for the first 21 days with more pronounced cell death observed by day 35 (SD 3). Ex vivo studies revealed similar trends and observations as those observed from in vitro experiments.
For Alg only scaffolds LIVE/DEAD TM revealed limited migration and infiltration of resident AF cells from the surrounding AF tissue after 5 weeks of implantation (Figure 6(b) and (c) ). This was also confirmed through SEM analyses ( Figure 6(d) ). In comparison, Alg-Coll scaffolds appeared to stimulate cell recruitment from the peri-implant area, followed by attachment and migration into the scaffold. Indeed, on some external regions of the scaffolds which were in close contact with the native AF tissue, cells attached to the scaffolds creating a migratory front, with subsequent invasion into the porous network of composite constructs with high cell viability being maintained ( Figure 6 (e) to (g)). Histological analyses revealed that limited neo-ECM deposition was secreted by the infiltrated AF cells for both Alg and Alg-Coll constructs (data not shown).
In vitro cytocompatibility of MSCs on alginate-based scaffolds
Having demonstrated that the incorporation of collagen into alginate structures offered significant advantages in terms of AF cell adhesion and scaffold colonization for both in vitro and ex vivo conditions, we next explored
Alginate scaffold
Alginate -Collagen scaffold the use of these scaffolds in combination with MSCs. We hypothesized that by loading MSCs into the scaffold during implantation, matrix deposition could be enhanced. Evaluation in IVD-like microenvironmental conditions revealed that MSCs remained viable in both Alg and Alg-Coll scaffolds (unloaded, loaded with TGF-b3 or cultured in TGF-b3 supplemented media). By day 21, DNA quantification for the different scaffolds demonstrated higher cell numbers for Alg-Coll scaffolds compared to alginate only (>fivefold, Figure  7(a) ). Collagen content, which is a key constituent of the native AF ECM was determined using a hydroxyproline assay. Limited deposition of collagen was observed for Alg only scaffolds (in the presence or absence of TGF-b3 loaded in the scaffold or supplemented in the media, data not shown). In comparison, incorporation of collagen into the alginate-based scaffolds positively influenced matrix deposition by MSCs with the presence of TGF-b3 further enhancing matrix deposition ( Figure  7(b) ). Indeed, the amount of collagen quantified in constructs cultured in TGF-b3 supplemented media (XPAN þ TGF-b3) was 1.95-fold higher compared to unsupplemented media (XPAN) (with values corresponding to 26.5 and 13.6 mg/scaffold, respectively). Interestingly, the incorporation of TGF-b3 into Alg-Coll scaffolds appeared to stimulate collagen synthesis compared to cultivation in XPAN only (corresponding to 1.56-fold higher). For MSCs seeded onto Alg scaffolds, macroscopic imaging revealed limited colonization (Figure 7(c) ),
TGF-β3 loaded Alg
TGF-β3 loaded Alg-Coll similar to that previously observed for AF cells. LIVE/ DEAD Õ staining showed good cell viability, with cells exhibiting a rounded morphology (Figure 7(d) ). Histological staining using Picro Sirius Red confirmed the limited collagen deposition in alginate scaffolds (Figure 7 (e) and (f)). In comparison, for Alg-Coll scaffolds, higher cell activity was observed macroscopically, as the scaffolds were more opaque at the end of the culture period compared to alginate only ( Figure  7(g) ). MSCs exhibited a fibroblastic-like morphology with intense cytoplasmic spreading (Figure 7(h) ). Histological examination revealed positive collagen staining within the porous network of the constructs (Figure 7 (i) and (j)). Immunochemistry revealed collagen type I was deposited within the newly formed matrix (Figure 7 (k) and (l)), whereas no collagen type II was detected (data not shown).
Cell colonization of MSC-laden alginate-based scaffold in an organ culture model
Having demonstrated that the addition of collagen to the alginate scaffold stimulated MSCs to attach and to proliferate, and that the loading of TGF-b3 further enhanced matrix deposition; we next explored how this system would perform in an ex vivo organ culture model. For the different groups (Alg (Figure 8(a) ) and Alg-Coll (Figure 8(f) )), the implanted scaffolds remained in the defect site of the IVD for the 5 weeks of the experiment, with no variation in terms of volume or size observed. Control group, corresponding to MSCs injected in TGF-b3-loaded Alg scaffold, demonstrated limited cell proliferation into the scaffold after 5 weeks of culture but instead MSCs created small clusters, similar to that observed from in vitro experiments. The LIVE/DEAD TM assay demonstrated that the cells were mainly viable (Figure 8(b) and (c)) and that the clusters of cells were composed almost exclusively of MSC-labeled cells (Figure 8(d) ) (as the proportion of red-stained MSC-labeled cells was globally similar to the total cell population). The ability of native AF cells to migrate from the tissue surrounding defect site was limited (as previously demonstrated in vitro, Figure  6 ) even with the presence of MSCs.
In comparison, in Alg-Coll constructs, a higher number of cells were able to proliferate throughout the scaffold, and cells remained viable during the 5 weeks of the study (Figure 8 to Alg only, Alg-Coll composite scaffolds facilitated migration of AF cells from the surrounding tissue into the scaffold. By day 35, scaffolds were colonized by a heterogeneous cellular population based on MSCs (injected at day 0) and endogenous migrating AF cells (Figure 8 (g) to (i)). Additionally, SEM analyses confirmed cellular infiltration from the outer part of the Alg-Coll scaffold (Figure 8(j) ).
Discussion
Tissue engineering strategies for AF regeneration of the IVD are still in their infancy. 8, 9, 29 We have previously demonstrated that porous scaffolds based on covalently crosslinked alginate using carbodiimide chemistry is an attractive biomaterial for tissue repair. 16 Due to the chemical modification of the alginate chains, the resulting structure is more stable than alginate hydrogels typically obtained through ionic crosslinking, and more importantly, exhibits shape-memory properties upon hydration. Such physical characteristics are highly attractive to regenerate damaged tissues and offer the potential for minimal invasive surgery via injection with the ability to expand and fill defects of various shapes, geometries, and sizes. However, to foster regeneration, such scaffolds should facilitate cell attachment, migration, and colonization of the porous construct shortly after its insertion into the host tissue.
We have previously shown that AF cells isolated from porcine IVD have the capacity to proliferate in alginate scaffolds and to secrete a large amount of ECM in IVD-like microenvironmental condition in the presence of TGF-b3. 16 However, we observed that cells did not attach directly on the hydrophilic surface of the scaffold, which has also been reported by other authors. 30, 31 Indeed, structures fabricated from highly hydrophilic polymers do not lend themselves to protein adsorption and are therefore poor substrates for cellular adhesion. 11, 30 This characteristic has been largely observed in vitro for osteoblasts, 32, 33 skeletal myoblasts, 34 chondrocytes, 35, 36 hepatocytes, 37 and NP cells, 38, 39 where cells exhibited weak adhesion and proliferation after encapsulation in unmodified alginate.
Biomimetic-based scaffolds based on collagen have been investigated as potential candidates to regenerate the AF tissue 40,41 since collagen is a major biological constituent of the AF matrix (50-70% dry weight). 42 In addition, collagen exhibits several advantages in terms of immunogenicity and biocompatibility. 8 However, collagen-based constructs are inherently weak mechanically and are susceptible to shrinkage when cultured with cells limiting their applicability for tissue repair. Indeed, the reduction in volume of 3D collagen scaffolds after 35 days of in vitro cultivation has previously been reported to be up to ninefold 43 with concomitant loss in mass after only 14 days. 44, 45 We have previously demonstrated that alginate only scaffolds did not support cell attachment. 16 In the current study, in an attempt to enhance the ability of cells to adhere and to colonize the scaffold, we investigated the incorporation of collagen as a biological matrix into freeze-dried alginate porous constructs to overcome such limitations.
This collagen-enriched alginate scaffold exhibited similar physical properties to alginate only scaffold in terms of swelling, compressive, and shape-memory behavior. In addition, scaffolds retained their initial size and shape throughout experiments. Of interest from this work is the significant influence that collagen had in regulating cell behavior, in terms of cell shape/ morphology and migration. Preservation of AF cell phenotype during in vitro cultivation remains challenging as previous studies showed a tendency of the cells to differentiate toward an NP-like phenotype with overexpression of collagen type II and aggrecan genes. 46, 47 A major prerequisite for any cell-based therapies aiming to recreate biologically functional AF tissue is to be able to deliver the cells in an appropriate vehicle which maintains the correct cell phenotype. 48 In alginate only, AF cells exhibited a rounded shape morphology, closer to the chondrocyte-like phenotype of NP cells; whereas in collagen-enriched scaffolds, cells attached and exhibited an elongated fibroblastic-like phenotype, typical of AF cell morphology. 49 Ex vivo organ culture experiments are highly attractive as they more closely mimic the in vivo scenario, offering a more challenging environment than in vitro conditions. Discs isolated from the bovine coccygeal have been proposed as a suitable alternative to human IVD, in terms of ECM distribution, 50,51 swelling pressure, 52 and size 53 compared to other animal species and is easily accessible. Ex vivo organ culture experiments showed that TGF-b3-loaded Alg-Coll scaffolds significantly promoted recruitment of endogenous AF cells from the surrounding surgical defect area and infiltration into the 3D constructs compared to Alg only. However, in contrast to the in vitro migration studies which demonstrated rapid cellular colonization of Alg-Coll scaffolds, ex vivo organ culture studies on these acellular scaffolds revealed that the colonization by endogenous AF cells from the injured IVD is not rapid which may pose an issue for implant integration with host tissue.
As a consequence, cell-based approaches to promote IVD therapy have been proposed using transplanted autologous cultured disc-derived chondrocytes 54 or mesenchymal stem cells. 44, [55] [56] [57] [58] [59] See et al. demonstrated the potential of differentiating MSCs toward an inner-AF cell phenotype. 60, 61 Such strategies offer tremendous advantages compared to autologous AF cell transplantation in terms of availability, ease of harvesting, tissue morbidity, pain, and subsequent risk of disc herniation for the donor. In this study, we showed that, in vitro, under IVD-like microenvironmental conditions, collagen-alginate scaffolds were capable of maintaining MSC viability and facilitated matrix accumulation. Moreover, accumulation of collagen into the scaffold (collagen type I) was stimulated by the intrinsic delivery of growth factor (TGF-b3) compared to TGF-b3 free media. Organ culture experiments containing scaffolds seeded with MSCs facilitated the retention and sustained the survival of transplanted MSCs for at least 5 weeks. This is a primary prerequisite for cell-based therapy as the risk of cell leakage and poor cell survival postinjection into the center of the IVD has been well documented in ex vivo experiments. 62 Microscopic analyzes performed on scaffolds at the end of the culture study revealed the presence of a heterogeneous cellular population, consisting of a mixture of MSCs and endogenous AF cell population from the donor site. However, histological evaluation of excised constructs revealed limited tissue ingrowth within the porous constructs. From this preliminary work, we showed that delivering a scaffold seeded with MSCs to a damaged area of the IVD offers limited benefit in terms of tissue regeneration. A number of aspects may need to be optimized in order to elicit a beneficial response such as better control of growth factor release kinetics, increasing the seeding density of MSCs, and possibly predifferentiation of MSCs prior to transplantation.
In our study, we did not observe differences in terms of AF cell migration and MSC proliferation with TGF-b3 loaded scaffolds compared to unloaded scaffolds, which could clearly restrict the biological activity of this bioactive scaffold system. There are a number of aspects that could be explored or optimized to improve the release kinetics of growth factors by covalently crosslinking to the scaffold. 63 This strategy may prolong the retention of the active cues in the scaffold environment and has been successfully applied for many biomedical applications including bone 64 and cartilage. 65 However, short-term TGF-b3 exposure in loaded scaffolds did positively influence subsequent collagen deposition by MSCs. This is consistent with the work by Huang et al. which showed that continuous TGF-b3 supplementation did not enhance MSC proliferation, but actually increased glycosaminoglycan (GAG) and collagen accumulation. 66 Another limitation of these scaffold materials is the mechanical properties, which are significantly lower than native AF tissue. 16 Nevertheless, the function and biological role of such an injectable porous scaffold is to fill the tissue defect, to support cell penetration and matrix deposition. Regarding the manipulation of MSCs prior to transplantation, several approaches could be worth exploring. Activation of MSCs toward an AF cell phenotype could be investigated in a coculture model 67 or by predifferentiation of pluripotent stem cells prior to transplantation, which has been investigated for articular cartilage regeneration. 68 Seeding cell density is also an important factor that could be investigated, as it directly impacts cell growth and survival, 69 and could consequently increase matrix formation. Nonetheless, the ex vivo IVD culture system described in this study provides an attractive model for screening therapeutic systems intended to treat AF defects prior to large animal trials.
However, the authors are conscious of the limitations of such ex vivo models. Recent investigations performed on whole IVDs have demonstrated that organs responded to the artificial environment with a degenerative process, 70, 71 which seems to be even exacerbated during the cultivation of IVDs under free-swelling condition. Indeed, mechanical stimulus is known to influence cell phenotype and differentiation, 61 tissue viability, 70 metabolism activity, 72 matrix organization, 73 and tissue remodeling 74 on disc cells. In this study, the culturing of IVDs under free-swelling condition during the 5 weeks of the culture period could explain the poor ECM accumulation observed in the implanted scaffolds. Another important issue to question is how these implanted scaffolds would respond in a loaded mechanical environment. Risk of implant migration and extrusion must be assessed, and sealant materials (i.e. fibrin glue, 75, 76 genipin crosslinking, 77 or biodegradable glue 78 ) warrant further investigations. However, further investigations will be required to determine if the addition of collagen into the alginate scaffold will elicit a beneficial response in vivo in terms of tissue integration, without fibrosis and scar tissue formation, as has previously been observed for collagen-based scaffolds. 13 
Conclusion
Regeneration of damaged AF tissue using tissue engineering strategies remains a significant challenge. In this work, we demonstrated that collagen can be incorporated into alginate-based shape-memory scaffolds offering advantages over alginate or collagen alone, in terms of mechanical stability, injectability, and biological activity, which are highly attractive for the regeneration of AF tissue. In vitro studies demonstrated that the addition of collagen into the preformed alginate scaffolds promoted AF cell penetration preserving the natural cell phenotype. In MSC-seeded scaffolds, the incorporation of collagen had a beneficial effect on cell proliferation and ECM deposition, and the matrix secretion was amplified by the local release of TGF-b3 growth factor compared to nonsupplemented media. Ex vivo experiments demonstrated that such scaffolds were able to be administered into defects occurring in the AF tissue in a minimally invasive fashion to fill the defect site. Collagen-enriched scaffolds maintained MSC viability and allowed attachment of endogenous AF cells from the surrounding tissue and infiltration into the 3D constructs compared to alginate only scaffolds.
